Genetic characterization of the ABO blood group in Neandertals by Lalueza-Fox, Carles et al.
This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted
PDF and full text (HTML) versions will be made available soon.
Genetic characterization of the ABO blood group in Neandertals
BMC Evolutionary Biology 2008, 8:342 doi:10.1186/1471-2148-8-342
Carles Lalueza-Fox (carles.lalueza@upf.edu)
Elena Gigli (giglielena@yahoo.it)
Marco de la Rasilla (mrasilla@uniovi.es)
Javier Fortea (fortea@uniovi.es)
Antonio Rosas (arosas@mncn.csic.es)
Jaume Bertranpetit (jaume.bertranpetit@upf.edu)
Johannes Krause (krause@eva.mpg.de)
ISSN 1471-2148
Article type Research article
Submission date 5 October 2008
Acceptance date 24 December 2008
Publication date 24 December 2008
Article URL http://www.biomedcentral.com/1471-2148/8/342
Like all articles in BMC journals, this peer-reviewed article was published immediately upon
acceptance. It can be downloaded, printed and distributed freely for any purposes (see copyright
notice below).
Articles in BMC journals are listed in PubMed and archived at PubMed Central.
For information about publishing your research in BMC journals or any BioMed Central journal, go to
http://www.biomedcentral.com/info/authors/
BMC Evolutionary Biology
© 2008 Lalueza-Fox et al. , licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 1
Genetic characterization of the ABO blood group in Neandertals
Carles Lalueza-Fox1, Elena Gigli1, Marco de la Rasilla2, Javier Fortea2, Antonio Rosas3,
Jaume Bertranpetit1 and Johannes Krause4
1Institut de Biologia Evolutiva, UPF-CSIC, Dr. Aiguader 88, 08003 Barcelona, Spain.
2Área de Prehistoria, Departamento de Historia, Universidad de Oviedo, Teniente
Alfonso Martínez s/n, 33011 Oviedo, Spain.
3Departamento de Paleobiología, Museo Nacional de Ciencias Naturales, CSIC, José
Gutierrez Abascal 2, 28006 Madrid, Spain.
4Department of Evolutionary Genetics, Max Planck Institute for Evolutionary
Anthropology, Deutscher Platz 6, 04103 Leipzig, Germany.
Corresponding author:
Carles Lalueza-Fox
Institut de Biologia Evolutiva, CSIC-UPF,
Dr. Aiguader 88, 08003 Barcelona, Spain.
Email:carles.lalueza@upf.edu
Phone: +34 933160845
Elena Gigli: giglielena@yahoo.it
Marco de la Rasilla: mrasilla@uniovi.es
Javier Fortea: fortea@uniovi.es
Antonio Rosas: arosas@mncn.csic.es
Jaume Bertranpetit: jaume.bertranpetit@upf.edu
Johannes Krause : krause@eva.mpg.de
 2
Abstract
Background: The high polymorphism rate in the human ABO blood group gene seems
to be related to susceptibility to different pathogens. It has been estimated that all
genetic variation underlying the human ABO alleles appeared along the human lineage,
after the divergence from the chimpanzee lineage. A paleogenetic analysis of the ABO
blood group gene in Neandertals allows us to directly test for the presence of the ABO
alleles in these extinct humans.
Results: We have analysed two male Neandertals that were retrieved under controlled
conditions at the El Sidron site in Asturias (Spain) and that appeared to be almost free
of modern human DNA contamination. We find a human specific diagnostic deletion
for blood group O (O01 haplotype) in both Neandertal individuals.
Conclusions: These results suggest that the genetic change responsible for the O blood
group in humans predates the human and Neandertal divergence. A potential selective
event associated with the emergence of the O allele may have therefore occurred after
humans separated from their common ancestor with chimpanzees and before the
human-Neandertal population divergence.
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Background
The ABO blood group system was the first genetic polymorphism discovered in
humans. It consists of three alleles: two co-dominant A and B alleles, and one silent and
recessive O allele[1]. The system is controlled by a single gene at the ABO locus. This
gene encodes a glycosyltransferase enzyme that adds a sugar residue to a carbohydrate
structure known as the H antigen, that is present in the membrane of red cells as well as
most epithelial and endothelial cells. The A allele codes for an enzyme that adds a N-
acetyl galactosamine to the H antigen, while the B allele, which differs from the former
by four amino acid changes, codes for an enzyme that adds a D-galactose. The O allele
occurs most frequently in modern humans and carries a human-specific inactivating
mutation which produces a non-functional enzyme, and thus the H antigen remains
without further modification on the surface of the cells [2,3]. The combination of the
three ABO alleles results in four major phenotypes, named A, B, AB and O, these carry
different antigens (A, B, both and neither, respectively) that react with specific
antibodies [1].
The ABO gene is organized in 7 exons that range in size from 28 to 688
nucleotides, with exon 6 and 7 being the largest [2,4]. Further analyses of the ABO gene
have shown that, at the nucleotide sequence level, numerous haplotypes exist among
modern humans[5]. The main A and B alleles (hereafter A101 and B101, respectively)
differ by four amino acid changes at positions 176, 235, 266 and 268 (nucleotide
positions are numbered starting from the first nucleotide of exon 1), with the two later
being determining the A and B specificity of the enzyme. The most frequent among all
human ABO alleles is the O allele [6]. The most frequent O haplotypes, O01 and O02,
share a single G nucleotide deletion in position 261 of exon 6 (∆261) that creates a
premature stop codon and results in a truncated protein with no enzymatic activity [7];
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they are referred as the O (∆261) alleles below. The O01 haplotypes differ from the O02
haplotypes by at least six nucleotide substitutions, including position 297 in exon 6,
which is A in the former and G in the latter.
Many studies have examined the association between the ABO alleles and a
variety of diseases [8], mainly focussed on infectious agents that can use the A and B
antigens as receptors, or in case of the O allele, the absence of the A and B antigens.
The O allele can provide a selective advantage since it also produces both anti-A and
anti-B antibodies [9]. In particular, it has been suggested that the O allele protects
against severe malaria [10]. At the same time, it can be more sensitive to Helicobacter
pylori infections [11] and to severe forms of cholera [12]. The complex pattern of
putative selective agents favouring or acting against different alleles could explain the
maintenance of the high ABO polymorphism [13], as evidenced by the signal of
balancing selection detected on the gene [14,15]. Therefore studying the evolution of
the ABO blood groups to determine when during human history the different alleles
emerged may contribute to our understanding on what selective forces might have
worked on the different alleles.
Within the apes a convergent evolution of the different blood groups can be
observed, although no ape displays all three phenotypes known in humans [3]. Whereas
all gorillas studied to date carry only an allele that has properties similar to the human B
allele, our closest living relative, the chimpanzee carries two alleles corresponding to
the human A and O. Both alleles in the chimpanzee are characterized by species specific
mutations in the ABO gene that are distinct from those found in humans [3]. For the
ABO alleles on the human lineage it has been estimated that the B101 allele, which
gave rise to all the B variants, derived from the ancestral A101 allele around 3.5 million
years ago (Mya) [14], whereas the youngest and most common human allele O01,
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carrying the ∆261 deletion, derived from the A allele only about 1.15±0.2 Mya
determined by coalescence analysis [15]. The emergence of the ABO allele O01
therefore predates the mean divergence time for modern humans and Neandertals
estimated to more than 500 Kya [16, 17] and opens the possibility to put a lower limit
on the estimated coalescence date by directly testing for the presence of the O01 allele
in the Neandertal population. Thus we undertook a targeted approach to determine
whether the ∆261 deletion in the O allele was also present in Neandertals and by that
testing the emergence of the O01 allele in the common ancestor of modern human and
Neandertal.
Methods
DNA extraction and amplification.
We analysed two Neandertal samples from the El Sidrón site (Asturias, Spain)
[18-20] that were extracted in 2006 under controlled conditions (with excavators
completely outfitted in sterile lab gear, including coveralls, face mask, face shield and
gloves)[21] and immediately frozen, prior to sending them to the dedicated ancient
DNA laboratories in both Barcelona and Leipzig, where DNA extractions were
performed. About 500mg of cortical bone was removed, powdered and extracted as
described [20,22].
Analysis of specific nuclear DNA loci from ancient Neandertal remains by the
polymerase chain reaction (PCR) is a challenging task that presents two main
limitations: the small quantity and short length of ancient DNA fragments due to the
degradation of the original template molecules and the difficulty in distinguishing
between endogenous Neandertal DNA and putative contemporary modern human
contaminants. However, the presence of single informative substitutions in the ABO
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gene allows for characterization of the different alleles even when retrieving short DNA
sequences. Also, the co-amplification of mitochondrial DNA (mtDNA) and nuclear
markers allow us to control for the presence of human contamination in the extracts.
Two-step multiplex PCRs [23] in a total volume of 20 µl were set up and
incubated for 10 minutes at room temperature with 0.5 units of Shrimp Nuclease
(Biotec Pharmacon®) to degrade any double-stranded DNA that may contaminate the
reagents [24]. After inactivating the nuclease for 30 minutes at 65°C, 5 µl of extract and
TaqGold DNA polymerase were added to the PCR. Twenty-seven cycles of PCR were
performed in the first PCR and 33 cycles in the second PCR. Reaction conditions were
as described [24] except for the annealing temperature, which was 53-55°C, depending
on the primers used.
The informative ∆261 position in exon 6 was amplified with the F20144-
AGGAAGGATGTCCTCGTGG, R20163-TGCCCTCCCAGACAATGG primer couple
(numbered according to the GenBank RefSeq AY268591). The 297 position in exon 6,
further retrieved to determine to which of the two main O haplotypes (O01 or O02) the
specimens belonged, was amplified with the F20173-
TTGGCTGGCTCCCATTGTCTGG, R20194-GAACTGCTCGTTGAGGATG primer
couple. The PCR products were 55 and 61 bp in length, respectively. In Barcelona,
amplification products of the correct size were cloned using the TOPO TA cloning kit
(Invitrogen), and several clones from each product were sequenced using an ABI3730
capillary sequencer (Applied Biosystems) following the manufacturer’s instructions. In
Leipzig, the products from each PCR were pooled and ligated with a specific tagging
sequence for each PCR as described [25] and subsequently sequenced on a 454 FLX
machine.
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Contamination controls
To determine the degree of modern human contamination in the Neandertal
DNA extracts we amplified and sequenced, using conserved primers, one position in the
mitochondrial DNA (mtDNA) coding region (diagnostic transversion 6,267) from each
Neandertal extract where Neandertals were found to be distinct from modern humans
[17], as well as two diagnostic mtDNA Hypervariable Region I (HVR1) fragments
between positions 16,135-16,169 and 16,182-16,223. To ensure that the copy number of
nuclear DNA is sufficient for amplifying nuclear Neandertal DNA and to monitor
potential nuclear DNA contamination we additionally amplified a control position on
the Y-chromosome, which was previously described as ancestral in both specimens and
defines the deepest clade in the human Y-chromosome tree (Y2 in [24]). This clade is
comprised of all modern human Y chromosomes haplogroups outside Africa.
Successful amplifications of the Y chromosomal control fragment confirmed that the
two specimens labeled 1253 and 1351c come from two different male individuals [24].
Results and Discussion
In Barcelona, position 261 on exon 6 in the 1253 specimen was amplified in four
independent PCRs in parallel with the mtDNA controls (diagnostic transversion 6,267
and mtDNA HVR1 fragments) and the nuclear Y-chromosome position. The products
were cloned and at least 10 clones sequenced. The sequences from all four products for
the 1253 specimen (n=53) showed the ∆261 deletion, which defines the O alleles. All
Y2 sequences (n=8) were found to be ancestral (i.e., identical to the chimpanzee
sequence), while 35 out of 36 mtDNA sequences were Neandertal-specific. We further
amplified and sequenced position 297 on exon 6. Twelve sequences display an A at
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position 297, which is compatible with the most frequent O haplotype, the O01, but not
with the other, the O02 [5]. The position 261 on exon 6 was also amplified in four
independent PCRs from the specimen 1351c along with the Y2 fragment and the
informative mtDNA position 6,267. All the ABO sequences (n=55) were identical to
those found in the 1253 specimen, while all Y2 sequences (n=4) were ancestral, and 35
out of 36 mtDNA sequences were Neandertal specific (Table 1).
In Leipzig, position 261 and position 297 on exon 6 in specimen 1253 were
amplified in two independent 2-step Multiplex PCRs together with one of the
informative mtDNA fragments (position 6,267). All sequences for the 261 fragment in
the first PCR show ∆261 (n=40), for 20 of the sequences we find a additional C>T
substitution at position 263, a substitution at that position was not found in any other
PCR product from Leipzig or Barcelona and is likely to derive from a miscoding lesion
caused by deamination of cytosine on the ancient molecule [26,27]. For the second PCR
from specimen 1253, 39 sequences were found to carry the ∆261 and 21 displayed a G
at that position (Table 1). At position 297 an A was found in all clones from the first
PCR, while in the second PCR most of the sequences (n=49) display an A and others
(n=21) a G (Table 1). For specimen 1351c, just one PCR resulted in a product covering
position 261 where some sequences displayed the ∆261 (n=43) and some showed no
deletion (n=41). All the sequences (n=50 and 41) in the two independent PCRs for
specimen 1351c showed an A at position 297.
Between 82% and 825% Neandertal sequences were found for the informative
mtDNA fragments that were co-amplified along the ABO positions. Despite the
informative transversion at position 6,267 where humans have a A and Neandertals a C,
there is a second diagnostic position, 6,261, present in that fragment where most
humans have a G and Neandertals an A [17]. All clones for the mtDNA fragments show
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either the 6,267A-6,261G or the 6,267C-6,261A haplotype, allowing to determine
whether they derived from human or Neandertal, respectively. There is also a number of
transitions present in a minority of the mtDNA sequences that are almost all either C>T
or G>A substitutions typical for miscoding lesions [26,27]. Furthermore we find a
number of insertions and deletions close to homopolymers, a known problem of the 454
technology [17]. Only little post-mortem damage was found in the nuclear sequences
retrieved in Leipzig and Barcelona (see Additional File 1, Table S1), which can be
attributed to the small number of individual clone sequences obtained, the short length
of the amplified product and a low molecule starting number for the PCR. The later
explanation is supported by some unsuccessful amplifications in both Barcelona and
Leipzig, and also by the almost equal ratio of clones that show the C>T transition at
position 263 for one of the 261 fragments, suggesting the PCR started only from two
initial DNA molecules (see Additional File 1 Table S1).
The low level of modern human mtDNA contamination and the fact that from
both specimens ancestral Y chromosomal positions could be repeatedly retrieved
suggest that the majority of the ABO fragments amplified in this study derive from
Neandertal nuclear DNA. Since nine out of eleven successful amplifications of position
261 from both Neandertals only displayed the informative deletion for allele O, we
conclude that this allele was present in the Neandertal population. Since four out of five
amplifications of position 297 only displayed an A at that position, it is likely that the
haplotype was O01. If we assume that our amplifications just start from single
molecules and that our Neandertals are heterozygous at position 261, it seems quite
unlikely to observe only one of six and one of five PCRs for the second individual
without the ∆261 (1253 p=0.093; 1351c p=0.15). Given an average contamination rate
of 9.7 % with a probability of carrying either the A or the B allele of 0.7 (estimated
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from the current European population) the chances of this observation would increase
(1253 p=0.29; 1351c p=0.25).
Conclusions
Our results indicate that the two El Sidrón Neandertal individuals were most
likely homozygous for the O01 allele. Nevertheless given a low rate of potential modern
human contaminants in an unknown allelic state, we cannot discard the possibility that
both Neandertals could have been heterozygous (e.g. OA or OB). The results however
suggest the presence of the human O01 allele already in the common ancestor of
Neandertals and modern humans and thereby confirming an emergence of the O01
allele more than 1Mya predating the divergence of the modern human and Neandertal
populations. An alternative possibility would be that Neandertals have acquired this
allele by gene flow from modern humans, although at present, other genetic evidences
suggest that this scenario is unlikely [17,24]. Furthermore a potentially homozygous
state in at least two Neandertals, even though from the same group, at least indicates
that a potential selective advantage of the O allele could have also been present in the
Neandertal population. Future analyses regarding the frequency of the ABO alleles will
be necessary to reveal if all three genotypes were conserved in the Neandertal
population.
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Tables
Table 1. Sequencing results for the 1253 and 1351c Neandertal specimens, with ABO
polymorphic positions. (∆261): deletion in position 261. (261G): G in position 261.
(297A): A in position 297. (297G): G in position 297. (Y2): Y chromosome basal
marker. (An): ancestral. (nt 6,267): mtDNA nucleotide position 6,267. (Ne): Neandertal.
(MH): Modern human. (HVR1): mtDNA hypervariable region 1. (B): Barcelona; (L):
Leipzig. (Na): no amplification product obtained. (–): no amplification attempted.
Sample PCR ∆261 261G 297A 297G Y2 An 6,267 Ne 6,267 MH HVR1 Ne HVR1 MH
1253 1B 15 0 12 0 8 - - - -
1253 2B 10 0 - - - 15 1 9 0
1253 3B 15 0 - - - - - 12 0
1253 4B 13 0 - - - - - - -
1253 1L 39 21 5 0 - 188 29 - -
1253 2L 40 0 49 21 - 146 32 - -
1351c 1B 10 0 Na Na 4 - - - -
1351c 2B 10 0 - - - 13 1 - -
1351c 3B 16 0 - - - - - - -
1351c 4B 19 0 - - - - - - -
1351c 1L Na Na 50 0 - 191 31 - -
1351c 2L 43 41 41 0 - 186 26 - -
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